The 12th annual School of Graduate Studies in the Health Sciences' Research Day was held Oct. 26, 2018, in the Norman C. Nelson Student Union at UMMC. The all-day event began with breakfast and selected oral presentations from post-docs. Following the oral presentations, posters filled the Nelson Student Union gymnasium, where the graduate students and postdoctoral fellows showcased their research. During the Distinguished Alumni Luncheon, Dr. P. David Rogers received the Distinguished Alumni Award.
Dr. P. David Rogers holds the First Tennessee Endowed Chair of Excellence in Clinical Pharmacy and is Professor of Clinical Pharmacy and Pediatrics at the University of Tennessee Health Science Center Colleges of Pharmacy and Medicine. He also serves as Vice Chair for Research for the Department of Clinical Pharmacy and Translational Science, the Director of Clinical and Experimental Therapeutics, and Co-Director of the UTHSC Center of Excellence for Pediatric Experimental Therapeutics.
Dr. Rogers completed his undergraduate work at the University of Memphis, earned a Pharm.D. degree from the University of Tennessee, and M.S. and Ph.D. degrees in Microbiology and Immunology from the University of Mississippi Medical Center. He completed an American Society of Health-System Pharmacists (ASHP) accredited residency in Pharmacy Practice at the Regional Medical Center at Memphis, as well as an ASHP accredited Residency in Infectious Diseases Pharmacy Practice and Fellowship in Infectious Diseases Pharmacotherapy at the University of Mississippi Medical Center. Dr. Rogers is an elected Fellow of the American College of Clinical Pharmacy (ACCP) and has served on the Board of Directors of the ACCP Research Institute and the Society of Infectious Diseases Pharmacists. He is also a member of the American Associations of Colleges of Pharmacy and the American Society for Microbiology. He currently serves as a member of the NIH Drug Discovery and Mechanisms of Antimicrobial Resistance (DDR) Study Section.
Dr. Rogers’ research is supported through grants from associations, industry, and the National Institutes of Health (NIH). His research program has been continuously funded by NIH for almost two decades and he currently serves as Principle Investigator for two NIH R01 grants. He has authored over 100 publications, and over 140 scientific abstracts to date. The focus of his current work is on elucidating the molecular and genetic basis of antifungal drug resistance.